PLHIV
![January 2024: Transitional community adherence support for people leaving incarceration in South Africa — a pragmatic, open-label, randomized controlled trial](https://icap.columbia.edu/wp-content/uploads/JC-2.jpg)
January 2024: Transitional community adherence support for people leaving incarceration in South Africa — a pragmatic, open-label, randomized controlled trial
Article and Study Summary: Transitional community adherence support for people leaving incarceration in South Africa: a pragmatic, open-label, randomized controlled trial Published in: The Lancet HIV. 2024;11(1):e11-e19 https://doi.org/10.1016/S2352-3018(23)00235-7...Epidemiology of Tuberculosis Among People Living With HIV in the African Cohort Study from 2013 to 2021
Authors: Kavitha Ganesan, Ronald Mwesigwa, Nicole Dear, Allahna L Esber, Domonique Reed, Hannah Kibuuka, Michael Iroezindu, Emmanuel Bahemana, John Owuoth, Valentine Singoei, Jonah Maswai, Ajay P Parikh, Trevor A Crowell, Julie A Ake, Christina S Polyak, Neha...![April 2022: Single-dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis](https://icap.columbia.edu/wp-content/uploads/unnamed-3-1080x675.jpg)